Polycystic ovary syndrome, androgen excess, and the risk of nonalcoholic fatty liver disease in women: A longitudinal study based on a United Kingdom primary care database.

Antiandrogen therapy was associated with reduced hazard, but this did not reach statistical significance (HR = 0.80, 95% CI 0.59–1.097, p = 0.16) ( Table 4 ).

also in 111,027 other papers

Of note, antiandrogen treatment was associated with a reduction in NAFLD rate, though this failed to reach statistical significance, likely due to the limited number of women on antiandrogens in our cohort.

also in 6,035 other papers